Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laborator... Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland. Mehr anzeigen
Highlights Full year 2025 revenue guidance in the range of $8,050 - $8,650 million; midpoint of $8,350 million representing growth of approximately 1% over full year 2024 revenue guidance...
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released the findings of a survey of over 120 biotech and pharma professionals...
ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the 43rd Annual J.P...
ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured with numerous awards in the second half of 2024. On TIME Magazine’s 2024...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organisation, today announced the appointment of Barry Balfe as Chief Operating Officer (COO). Barry is a...
Survey spotlights shifting expectations and more measured pace of innovation as use of digital solutions matures within the biotech and pharma industry ICON plc, (NASDAQ: ICLR) a world-leading...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -3.52 | -1.72549019608 | 204 | 205.95 | 197.64 | 957806 | 201.70551289 | CS |
| 4 | -12.32 | -5.78947368421 | 212.8 | 228.285 | 196.5 | 902981 | 207.93797903 | CS |
| 12 | -21.96 | -9.87232512138 | 222.44 | 231.89 | 183.38 | 1226918 | 209.46030224 | CS |
| 26 | -131.38 | -39.5889833062 | 331.86 | 338.8 | 183.38 | 982593 | 241.02742925 | CS |
| 52 | -66.13 | -24.8040208544 | 266.61 | 347.7225 | 183.38 | 772616 | 266.81368234 | CS |
| 156 | -46.03 | -18.6726704799 | 246.51 | 347.7225 | 171.43 | 640389 | 243.43159844 | CS |
| 260 | 24.84 | 14.1425643361 | 175.64 | 347.7225 | 104.275 | 560704 | 233.73634527 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
